Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.40%288.17K | 3.88%1.41M | 67.13%382.31K | 87.39%456K | -43.56%293.25K | -23.84%278.7K | -10.03%1.36M | -25.67%228.75K | -38.97%243.34K | 34.47%519.62K |
| Operating revenue | 3.40%288.17K | 3.88%1.41M | 67.13%382.31K | 87.39%456K | -43.56%293.25K | -23.84%278.7K | -10.03%1.36M | -25.67%228.75K | -38.97%243.34K | 34.47%519.62K |
| Cost of revenue | -2.51%162.13K | -12.56%801.09K | 16.84%242.3K | 62.08%252.07K | -57.59%140.41K | -25.15%166.32K | -19.33%916.19K | -56.84%207.38K | -35.63%155.52K | 61.34%331.1K |
| Gross profit | 12.14%126.04K | 38.00%609.18K | 555.08%140.02K | 132.22%203.94K | -18.93%152.84K | -21.81%112.39K | 18.25%441.45K | 112.38%21.37K | -44.11%87.82K | 4.04%188.52K |
| Operating expense | 19.11%825.28K | 18.42%3.77M | 51.31%1.21M | 18.18%955.56K | 21.42%916.64K | -15.98%692.88K | -10.98%3.19M | -4.66%799.35K | -0.57%808.56K | -33.02%754.93K |
| Selling and administrative expenses | 4.63%449.7K | 22.17%2.46M | 63.82%825.15K | 25.19%635.02K | 20.10%566.21K | -18.61%429.8K | -21.31%2.01M | -8.72%503.69K | -9.22%507.24K | -46.05%471.46K |
| -Selling and marketing expense | -2.84%162.15K | 142.90%453.35K | 76.89%-79.25K | 19.42%198.02K | 4.66%167.7K | -17.99%166.88K | -56.89%186.64K | 40.92%-342.9K | -43.61%165.81K | -63.69%160.24K |
| -General and administrative expense | 9.37%287.55K | 9.81%2M | 6.83%904.4K | 27.99%437K | 28.05%398.51K | -19.00%262.91K | -14.05%1.82M | -25.23%846.59K | 28.99%341.43K | -28.06%311.22K |
| Research and development costs | 52.08%224.84K | 4.53%792.12K | 22.92%226.62K | -0.92%194.19K | 24.77%223.47K | -25.46%147.84K | -5.65%757.82K | -14.47%184.37K | -3.41%196K | -9.08%179.11K |
| Depreciation amortization depletion | 30.80%150.74K | 25.53%526.29K | 41.74%157.74K | 19.96%126.35K | 21.65%126.95K | 17.28%115.25K | 88.41%419.25K | 56.72%111.29K | 104.26%105.33K | 85.66%104.36K |
| -Depreciation and amortization | 30.80%150.74K | 25.53%526.29K | 41.74%157.74K | 19.96%126.35K | 21.65%126.95K | 17.28%115.25K | 88.41%419.25K | 56.72%111.29K | 104.26%105.33K | 85.66%104.36K |
| Operating profit | -20.46%-699.25K | -15.27%-3.17M | -37.47%-1.07M | -4.28%-751.62K | -34.85%-763.8K | 14.75%-580.5K | 14.38%-2.75M | 23.05%-777.97K | -9.85%-720.74K | 40.12%-566.41K |
| Net non-operating interest income (expenses) | 2.27%-89.87K | -23.24%-358.09K | 41.73%-55.26K | -43.34%-109.72K | -302.35%-101.15K | -71.83%-91.96K | -134.06%-290.56K | -143.35%-94.84K | -71.67%-76.55K | 264.82%49.99K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --51.62K |
| Non-operating interest expense | -2.27%89.87K | 23.24%358.09K | -41.73%55.26K | 43.34%109.72K | 6,113.21%101.15K | 71.83%91.96K | 134.06%290.56K | 143.35%94.84K | 71.67%76.55K | -94.63%1.63K |
| Other net income (expenses) | -274.51%-23.3K | -21.12%-63.09K | 305.69%46.94K | -3,800.78%-75.17K | 77.43%-28.64K | 61.27%-6.22K | -744,000.00%-52.09K | -3,374.03%-22.82K | 78.92%-1.93K | -2,215.93%-126.91K |
| Gain on sale of security | -197.63%-8.8K | -86.62%-53.12K | 92.28%-443 | -98.13%-25.36K | -267.73%-24.36K | 10.43%-2.96K | -7,016.25%-28.47K | -1,988.16%-5.74K | -40.01%-12.8K | -20.89%-6.63K |
| Special income (charges) | ---- | 321.12%39.71K | 522.54%47.93K | -124.63%-2.79K | -4.58%-5.43K | --0 | ---17.96K | ---11.34K | --11.34K | ---5.19K |
| -Less:Other special charges | ---- | ---48.01K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Write off | ---- | -53.76%8.3K | -99.29%80 | 124.63%2.79K | 4.58%5.43K | --0 | --17.96K | --11.34K | ---11.34K | --5.19K |
| Other non-operating income (expenses) | -344.05%-14.51K | -777.05%-49.68K | 90.39%-551 | -9,902.55%-47.01K | 101.00%1.15K | ---3.27K | -1,541.22%-5.66K | ---5.74K | ---470 | ---115.1K |
| Income before tax | -19.71%-812.41K | -16.12%-3.59M | -20.34%-1.08M | -17.18%-936.51K | -38.90%-893.58K | 9.58%-678.67K | 7.29%-3.09M | 14.65%-895.63K | -12.59%-799.22K | 34.47%-643.34K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -19.71%-812.41K | -16.12%-3.59M | -20.34%-1.08M | -17.18%-936.51K | -38.90%-893.58K | 9.58%-678.67K | 7.29%-3.09M | 14.65%-895.63K | -12.59%-799.22K | 34.47%-643.34K |
| Net income continuous operations | -19.71%-812.41K | -16.12%-3.59M | -20.34%-1.08M | -17.18%-936.51K | -38.90%-893.58K | 9.58%-678.67K | 7.29%-3.09M | 14.65%-895.63K | -12.59%-799.22K | 34.47%-643.34K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -19.71%-812.41K | -16.12%-3.59M | -20.34%-1.08M | -17.18%-936.51K | -38.90%-893.58K | 9.58%-678.67K | 7.29%-3.09M | 14.65%-895.63K | -12.59%-799.22K | 34.47%-643.34K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -19.71%-812.41K | -16.12%-3.59M | -20.34%-1.08M | -17.18%-936.51K | -38.90%-893.58K | 9.58%-678.67K | 7.29%-3.09M | 14.65%-895.63K | -12.59%-799.22K | 34.47%-643.34K |
| Diluted earnings per share | 25.00%-0.006 | 25.00%-0.03 | 27.27%-0.008 | 20.00%-0.008 | 0.00%-0.01 | 20.00%-0.008 | 20.00%-0.04 | 45.00%-0.011 | 0.00%-0.01 | 0.00%-0.01 |
| Basic earnings per share | 25.00%-0.006 | 25.00%-0.03 | 27.27%-0.008 | 20.00%-0.008 | 0.00%-0.01 | 20.00%-0.008 | 20.00%-0.04 | 45.00%-0.011 | 0.00%-0.01 | 0.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.